Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.

PubWeight™: 2.83‹?› | Rank: Top 1%

🔗 View Article (PMID 11549531)

Published in Am J Respir Crit Care Med on September 01, 2001

Authors

D E O'Donnell1, S M Revill, K A Webb

Author Affiliations

1: Respiratory Investigation Unit, Department of Medicine, Queen's University, Kingston, Ontario, Canada. odonnell@post.queensu.ca

Associated clinical trials:

Slow Chest Compression on Dynamic Hyperinflation, Dyspnea and Peripheral Muscle Deoxygenation in Patients With COPD | NCT02746536

Pursed-lips Breathing and Dynamic Hyperinflation | NCT02203058

Effect of Expiratory Positive Pressure on Dynamic Hyperinflation and Ability to Exercise With Upper Limbs in COPD | NCT03073564

Effect of Portable NIV on Operational Chest Wall Volumes in COPD | NCT03848819

Articles citing this

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27

Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax (2004) 2.40

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32

Dynamic laryngeal narrowing during exercise: a mechanism for generating intrinsic PEEP in COPD? Thorax (2015) 2.00

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Int J Chron Obstruct Pulmon Dis (2012) 1.52

Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax (2004) 1.36

Effect of inspiratory muscle work on peripheral fatigue of locomotor muscles in healthy humans. J Physiol (2005) 1.14

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. Drug Des Devel Ther (2010) 1.13

Pulmonary characteristics in COPD and mechanisms of increased work of breathing. J Appl Physiol (1985) (2009) 1.13

Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis (2006) 1.11

COPD exacerbations . 3: Pathophysiology. Thorax (2006) 1.06

Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One (2014) 1.04

Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.02

Respiratory kinematics by optoelectronic plethysmography during exercise in men and women. Eur J Appl Physiol (2004) 1.00

Impact of laughter on air trapping in severe chronic obstructive lung disease. Int J Chron Obstruct Pulmon Dis (2008) 0.95

Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.94

Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med (2010) 0.93

Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax (2005) 0.92

Pathophysiology of human ventilatory control. Eur Respir J (2014) 0.92

Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung (2013) 0.91

Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res (2011) 0.91

Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med (2008) 0.91

Dietary nitrate supplementation improves exercise performance and decreases blood pressure in COPD patients. Nitric Oxide (2014) 0.91

Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV. Int J Chron Obstruct Pulmon Dis (2008) 0.91

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.90

A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.90

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax (2006) 0.90

End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis (2008) 0.90

Benefits of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients. Int J Chron Obstruct Pulmon Dis (2008) 0.90

Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med (2010) 0.90

Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD. Pulm Med (2013) 0.89

An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease. Br J Clin Pharmacol (2006) 0.89

Influence of emphysema distribution on pulmonary function parameters in COPD patients. J Bras Pneumol (2015) 0.87

Continuous and intermittent exercise responses in individuals with chronic obstructive pulmonary disease. Thorax (2004) 0.86

Indacaterol: a comprehensive review. Int J Chron Obstruct Pulmon Dis (2013) 0.86

Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) (2012) 0.85

Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary Disease. Pulm Med (2012) 0.85

Assessing exercise limitation using cardiopulmonary exercise testing. Pulm Med (2012) 0.85

Mechanical ventilatory constraints during incremental cycle exercise in human pregnancy: implications for respiratory sensation. J Physiol (2008) 0.85

Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.84

Refractive errors and corrections for OCT images in an inflated lung phantom. Biomed Opt Express (2012) 0.84

Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study. BMC Pulm Med (2010) 0.84

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 0.84

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease. Respir Res (2012) 0.83

Exercise performance and differences in physiological response to pulmonary rehabilitation in severe chronic obstructive pulmonary disease with hyperinflation. J Bras Pneumol (2016) 0.83

Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients. Int J Chron Obstruct Pulmon Dis (2013) 0.83

Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation. Pulm Med (2013) 0.83

Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? NO. Can Fam Physician (2007) 0.82

Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. Int J Chron Obstruct Pulmon Dis (2011) 0.82

Does impaired O2 delivery during exercise accentuate central and peripheral fatigue in patients with coexistent COPD-CHF? Front Physiol (2015) 0.81

Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety. Int J Chron Obstruct Pulmon Dis (2008) 0.81

Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS One (2015) 0.81

The association between forced expiratory volume in one second (FEV1) and pulse oximetric measurements of arterial oxygen saturation (SpO2) in the patients with COPD: A preliminary study. J Res Med Sci (2014) 0.80

Single dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary disease. Lung (2006) 0.80

Impaired exercise ventilatory mechanics with the self-contained breathing apparatus are improved with heliox. Eur J Appl Physiol (2007) 0.80

Spirometric correlates of dyspnea improvement among emergency department patients with chronic obstructive pulmonary disease exacerbation. Respir Care (2008) 0.79

The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.79

Methods for Assessing Expiratory Flow Limitation during Tidal Breathing in COPD Patients. Pulm Med (2012) 0.78

Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium. Int J Chron Obstruct Pulmon Dis (2010) 0.78

The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. J Korean Med Sci (2015) 0.78

Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting. Int J Gen Med (2009) 0.78

Mechanisms of physical activity limitation in chronic lung diseases. Pulm Med (2012) 0.78

Medium term effects of including manual therapy in a pulmonary rehabilitation program for chronic obstructive pulmonary disease (COPD): a randomized controlled pilot trial. J Man Manip Ther (2016) 0.78

Oxygen kinetics and debt during recovery from expiratory flow-limited exercise in healthy humans. Eur J Appl Physiol (2006) 0.78

Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients. BMC Pulm Med (2014) 0.78

Expiratory flow limitation definition, mechanisms, methods, and significance. Pulm Med (2013) 0.78

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators. Tanaffos (2012) 0.77

Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD. Int J Gen Med (2012) 0.77

Test-Retest Reliability and Physiological Responses Associated with the Steep Ramp Anaerobic Test in Patients with COPD. Pulm Med (2012) 0.77

Exercise-Induced Changes in Exhaled NO Differentiates Asthma With or Without Fixed Airway Obstruction From COPD With Dynamic Hyperinflation. Medicine (Baltimore) (2016) 0.77

Dynamics of chest wall volume regulation during constant work rate exercise in patients with chronic obstructive pulmonary disease. Braz J Med Biol Res (2012) 0.77

Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? J Bras Pneumol (2014) 0.77

Dynamic hyperinflation and dyspnea during the 6-minute walk test in stable chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis (2015) 0.77

Alternatives to lung transplantation: lung volume reduction for COPD. Clin Chest Med (2011) 0.76

Non invasive ventilation as an additional tool for exercise training. Multidiscip Respir Med (2015) 0.75

Ventilatory demand and dynamic hyperinflation induced during ADL-based tests in Chronic Obstructive Pulmonary Disease patients. Braz J Phys Ther (2016) 0.75

The effects of high intensity exercise during pulmonary rehabilitation on ventilatory parameters in people with moderate to severe stable COPD: a systematic review. Int J Chron Obstruct Pulmon Dis (2014) 0.75

Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis. Ann Transl Med (2016) 0.75

Chronic obstructive pulmonary disease. Can Respir J (2007) 0.75

Exercise dyspnea in patients with COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.75

Involvement of Ca(2+) Signaling in the Synergistic Effects between Muscarinic Receptor Antagonists and β₂-Adrenoceptor Agonists in Airway Smooth Muscle. Int J Mol Sci (2016) 0.75

Air Current Applied to the Face Improves Exercise Performance in Patients with COPD. Lung (2015) 0.75

Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease. Ann Thorac Med (2015) 0.75

Pulmonary Rehabilitation in COPD: A Reappraisal (2008-2012). Pulm Med (2013) 0.75

Pulmonary rehabilitation coupled with negative pressure ventilation decreases decline in lung function, hospitalizations, and medical cost in COPD: A 5-year study. Medicine (Baltimore) (2016) 0.75

Reduced dynamic hyperinflation after LVRS is associated with improved exercise tolerance. Respir Med (2014) 0.75

Effect of physical training on fat-free mass in patients with chronic obstructive pulmonary disease (COPD). Ups J Med Sci (2014) 0.75

Effects of body mass index on task-related oxygen uptake and dyspnea during activities of daily life in COPD. PLoS One (2012) 0.75

Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD. PLoS One (2016) 0.75

Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Coil therapy for patients with severe emphysema and bilateral incomplete fissures - effectiveness and complications after 1-year follow-up: a single-center experience. Int J Chron Obstruct Pulmon Dis (2017) 0.75

Are 30 minutes of rest between two incremental shuttle walking tests enough for cardiovascular variables and perceived exertion to return to baseline values? Braz J Phys Ther (2015) 0.75

Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases. Front Physiol (2017) 0.75

A randomised controlled trial of supplemental oxygen versus medical air during exercise training in people with chronic obstructive pulmonary disease: supplemental oxygen in pulmonary rehabilitation trial (SuppORT) (Protocol). BMC Pulm Med (2016) 0.75

Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Ventilatory responses to prolonged exercise with heavy load carriage. Eur J Appl Physiol (2015) 0.75

Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis. Eur J Pediatr (2014) 0.75

EXPRESS: Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension. Pulm Circ (2017) 0.75

Respiratory Muscle Strength in Patients With Chronic Obstructive Pulmonary Disease. Ann Rehabil Med (2017) 0.75

Articles by these authors

Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.03

Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J (2005) 2.02

Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 2.01

Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J (2004) 1.98

Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis (1993) 1.72

Evaluation of the information needs of patients with chronic obstructive pulmonary disease following pulmonary rehabilitation: a focus group study. Chron Respir Dis (2007) 1.60

Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J (2001) 1.55

Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med (1997) 1.55

Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.23

Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med (1997) 1.10

General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am J Respir Crit Care Med (1998) 1.04

Mechanisms of exertional dyspnea in patients with cancer. J Appl Physiol (1985) (2007) 1.04

Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. Am Rev Respir Dis (1993) 1.03

Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med (1999) 1.03

Varicella-zoster infection in adults with cystic fibrosis: role of acyclovir. Scand J Infect Dis (1991) 1.02

Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol (1985) (1998) 1.01

Respiratory sensation during chest wall restriction and dead space loading in exercising men. J Appl Physiol (1985) (2000) 0.98

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax (2008) 0.98

Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? Chest (2000) 0.98

Prescription of aerobic exercise during pregnancy. Sports Med (1989) 0.95

Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J (2009) 0.94

The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med (1995) 0.92

Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest (1992) 0.91

Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. Chest (1996) 0.91

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax (2006) 0.90

Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax (2008) 0.85

Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax (1995) 0.84

Abnormal sarcoplasmic reticulum Ca2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease. Am J Physiol Cell Physiol (2008) 0.83

Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med (2007) 0.82

Breathlessness during induced lung hyperinflation in asthma: the role of the inspiratory threshold load. Am J Respir Crit Care Med (1995) 0.82

Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol (1985) (2008) 0.82

Muscle fiber type characteristics in females with chronic obstructive pulmonary disease. A preliminary study. J Mol Histol (2009) 0.79

Testing for exercise limitation in obstructive lung disease. Chest (1999) 0.75

Further research on the Endurance Shuttle Walk Test (EWST) is needed before the test is advocated for clinical practice and research. Chron Respir Dis (2006) 0.75

The effect of a time delay on the measurement of capillary blood gases. Respir Med (1996) 0.75

Severe exertional dyspnea in a patient with localized emphysema. Can Respir J (2000) 0.75

Nursing care study: accidental burial. Nurs Times (1978) 0.75

Coronary care: a patient with myocardial infarction. Nurs Times (1980) 0.75

Older patients with COPD: benefits of exercise training. Geriatrics (1993) 0.75

Pulmonary arteriovenous malformation as a cause of severe exertional dyspnoea. Int J Clin Pract (1999) 0.75

Vocal cord paralysis and respiratory muscle weakness: an unusual presentation of chronic polyneuropathy. Can Respir J (1998) 0.75